Drug tolerability in assisted reproduction techniques: a longitudinal study

References

• Aghssa, MM. Azargoon, A. Ramezanzadeh, F. Bagheri, M. (2008) A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles. Fertil Steril 90(4):1043–1048.
   PubMed Web of Science ®Google Scholar
• Al-Inany, H.G., Aboulghar, M., Mansour, R., and Proctor, M. (2005) Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Cochrane Database Syst Rev (2). Apr 18; (2): CD003719
   Google Scholar
• Alviggi, C., Revelli, A., Anserini, P., Ranieri, A., Fedele, L., Strina, I. (2007) A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF). Reprod Biol Endocrinol 5:45.
   PubMed Web of Science ®Google Scholar
• Banz, C., Diedrich, K., & Ludwig, M. (2002) Ganirelix (Orgalutran). Tägliche Praxis 43(1):193.
   Google Scholar
• Beavers, N. (1997) Two new fertility drugs offer convenient self-administration. Drug Topics 141(21):30–32.
   Google Scholar
• Burgues and the Spanish collaborative group on female hypogonadotrophic hypogonadism (2001) The effectiveness and safety of recombinant human Lh to support follicular evelopment induced by recombinant human FSH in WHO groupI anovulation: evidence from a multicentre study in Spain. Hum Reprod 16(12):2525–2532.
   Google Scholar
• Chen, L.N., (2009) Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization. Nan Fang Yi Ke Da Xue Xue Bao 29(1):100–104.
   Google Scholar
• Christianson, M.S., Barker, M.A., Schouweiler, C. and Lindheim, S.R. (2007) A retrospective comparison of clinical outcomes and satisfaction using reconstituted recombinant gonadotropins (rFSH) or cartridge rFSH with a pen device in donor oocyte cycles. Curr Med Res Opin 23(4):865–870.
   PubMed Web of Science ®Google Scholar
• Craenmehr, E., Bontje, P.M., Hoomans, E., Voortman, G. and Mannaerts, B.M. (2001) Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe. Reprod Biomed Online 3(3):185–189.
   Google Scholar
• Daya, S. (2004) Follicle-stimulating hormone in clinical practice: an update. Treat Endocrinol 3(3):161–171.
   Google Scholar
• Diedrich, K. (2002) Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: A randomized, comparative trial. Fertil Steril 78(3):520–528.
   Google Scholar
• Dickey, RP. Thornton, M. Nichols, J. Marshall, DC. Fein, SH. Nardi, RV. (2002) Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle(trademark)) and recombinant follitropin-(beta) for in vitro fertilization: A prospective, randomized study. Fertil Steril 77(6):1202–1208.
   Google Scholar
• Dore, P.C., Rice, C. and Killick, S. (1994) Human gonadotrophin preparations. May cause allergic reaction. BMJ. 308(6942):1509.
   Google Scholar
• Engmann, L. Shaker, A. White, E. Bekir, JS. Jacobs, HS. Tan, SL. (1998) Local side effects of subcutaneous and stimulation in in vitro fertilization: A prospective, randomized study. Fertil Steril 69(5):836–840.
   Google Scholar
• Feigenbaum, S. Miller, P. Kaufmann, R. Elkind-Hirsch, K. Fein, S. Marshall, H.D. (2001) A new highly purified human-derived FSH, Bravelle(trademark), is as effective and well tolerated as recombinant follitropin beta in ovulation induction in infertile women with ovulatory dysfunction. Today's Ther Trends 19(4):297–313.
   Google Scholar
• Gibreel, A. and Bhattacharya, S. (2010) Recombinant follitropin alfa/lutropin alfa in fertility treatment. Biologics 4:5–17.
   PubMedGoogle Scholar
• Giles, J., Requena, A., Guillen, A. and Garcia Velasco, J.A. (2004) Comparative, prospective, randomized study about the use of hp-HMG vs u-HMG in an egg donation program. Rev Iberoam Fertil Reprod Humana 21(5):313–319.
   Google Scholar
• Gillies, P.S. Faulds, D., Balfour, J.A. and Perry, CM. (2000) Ganirelix. Drugs 59(1):107–111.
   Google Scholar
• Goa, K.L. and Wagstaff, A.J. (1998) Follitropin alpha in infertility: A review. BioDrugs 9(3):235–260.
   Google Scholar
• Gocial, B., Keye, W.R., Fein, S.H. and Nardi, R.V. (2000) Subcutaneously administered repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Fertil Steril 74(1):73–79.
   Google Scholar
• Greco, E. Polonio-Balbi, P. Ferrero, S. Baroni, E. Ubaldi, F. Rienzi, L. . (2005) Use of a fully automated injector for self-administration of follitropin alpha in an IVF/ICSI programme. Reprod Biomed Online 11(4):415–420.
   Google Scholar
• Harika, G., Gabriel, R., Quereux, C., Wahl, P. and Lavaud, F. (1994) Hypersensitization to human menopausal gonadotropins with anaphylactic shock syndrome during a fifth in vitro fertilization cycle. J Assisted Reprod Genet 11(1):51–53.
   Google Scholar
• Harrison, S., Wolf, T. and Abuzeid, M.I. (2000) Administration of recombinant follicle stimulating hormone in a woman with allergic reaction to menotropin: A case report. Gynecol Endocrinol 14(3):149–152.
   PubMed Web of Science ®Google Scholar
• International Recombinant Human Chorionic Gonadotropin Study Group (2001) Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 75(6):1111–1118.
   Google Scholar
• Kaplan, P.F. Austin, D.J. and Freund, R. (2000) Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles. Am J Obstet Gynecol 182(6):1421–1426.
   Google Scholar
• Kettel, LM. Scholl, G. Bonaventura, L. Pang, S. Sacks, P. Chantilis, S. (2004) Evaluation of a pen device for self-adminstration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction. Reprod Biomed Online 9(4):373–380.
   PubMed Web of Science ®Google Scholar
• Kinoshita, T., Ootaka, K. and Ito, M. (1999) Delayed-type hypersensitivity reaction to human menopausal gonadotrophin. J Obstet Gynaecol Res 25(6):437–438.
   Google Scholar
• Kinoshita, T., Ootaka, K. and Itou, M. (2000) Adverse effects of injection site with hMG. Jpn J Fertil Steril 45(2):47–50.
   Google Scholar
• Lin, YH, Wen, YR., Chang, Y., Seow, KM., Hsieh, BC., Hwang, JL. (2010) Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study. Fertil Steril 94(1):179–183.
   Google Scholar
• Nahuis, M. van der Veen, F. Oosterhuis, J. Mol, BW. Hompes, P. van Wely, M. (2009) Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women. Int J Womens Health 1(1):205–211.
   Google Scholar
• Nichols, J., Knochenhauer, E., Fein, S.H., Nardi, R.V. and Marshall, D.C. (2001) Subcutaneously administered repronex(registered trademark)a in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment. Fertil Steril 76(1):58–66.
   Google Scholar
• Olivennes, F. Ayoubi, JM. Fanchin, R. Rongières-Bertrand, C. Hamamah, S. Bouchard, P. (2000) GnRH antagonist in single-dose applications. Hum Reprod Update. 6(4):313–317.
   Google Scholar
• Out, H.J., Reimitz, P.E. and Bennink, H.J. (1997) A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon). Fertil Steril 67(2):278–283.
   Google Scholar
• Pang, S. Kaplan, B. Karande, V. Westphal, LM. Scott, R. Givens, C. (2003) Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation. Reprod BioMed Online 7(3):319–326.
   Google Scholar
• Pang, S. and Kettel, L.M. (2007) Clinical Experiences of Integrating the Follistim Pen® for the Self-administration of Follitropin Beta into Ovarian Stimulation Treatment Regimens. Touch Briefings 20–22. fertility treatement review
   Google Scholar
• Platteau, P. Laurent, E. Albano, C. Osmanagaoglu, K. Vernaeve, V. Tournaye, H. (2003) An open, randomized single-centre study to compare the efficacy and convenience of follitropin (beta) administered by a pen device with follitropin (alpha) administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 18(6):1200–1204.
   Google Scholar
• Porter, R., Kissel, C., Saunders, H. and Keck, C. (2008) Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: Comparison of two follitropin injection pens. Curr Med Res Opin 24(3):727–735.
   PubMed Web of Science ®Google Scholar
• Rama Raju, G.A., Suryanarayana, K., Prakash, G.J. and Krishna, K.M. (2008) Comparison of follitropin-(beta) administered by a pen device with conventional syringe in an ART programme - A retrospective study. J Clin Pharm Ther 33(4):401–407.
   Google Scholar
• Redfearn, A., Hughes, E.G., O'Connor, M. and Dolovich, J. (1995) Delayed-type hypersensitivity to human gonadotropin: Case report. Fertil Steril 64(4):855–856.
   Google Scholar
• Schneeweiss, S. (2011) Postmarketing studies of drug safety. BMJ 342:d342.
   Google Scholar
• Sedbon, E., Wainer, R. and Perves, C. (2006) Quality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in France. Reprod Biomed Online 12(3):298–303.
   Google Scholar
• Somkuti, S.G., Schertz, J.C., Moore, M., Ferrande, L. and Kelly, E. (2006) Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women. Curr Med Res Opin 22(10):1981–1996.
   PubMed Web of Science ®Google Scholar
• Uptodate database (2011) Overview of treatment of female infertiity. Available at: External link http://www.uptodate.com/patients. Accessed January 2, 2011.
   Google Scholar
• Van Hooren, HG, Fischl, F- Aboulghar. Mares., Nicollet, B., Behre, HM. (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16(4):644–651.
   Google Scholar
• Voortman, G., van de Post, J., Schoemaker, R.C. and van Gerven, J.M. (1999) Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon) by pen-injector and syringe. Hum Reprod 14(7):1698–1702.
   Google Scholar
• Weiss, N. (2007) Gonadotrophin products: empowering patients to choose the product that meets their needs. Reprod Biomed Online 15(1):31–7.
   PubMed Web of Science ®Google Scholar
• Welcker, J.T., Nawroth, F. and Bilger, W. (2010) Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study. Reprod Biol Endocrinol 8:111.
   PubMed Web of Science ®Google Scholar